Bridger Management, LLC Atara Biotherapeutics, Inc. Transaction History

Bridger Management, LLC

$222 Million
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $5.2 Million - $10.4 Million	-616,488 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $4.56 Million - $6.17 Million	-310,100 Reduced 33.47%	616,488 $9.72 Million
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $4.78 Million - $7.13 Million	-398,600 Reduced 30.08%	926,588 $16.6 Million
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $4.44 Million - $5.71 Million	-344,457 Reduced 20.63%	1,325,188 $20.6 Million
Q1 2021 May 14, 2021	BUY	$14.0 - $20.72 $2.03 Million - $3 Million	144,885 Added 9.5%	1,669,645 $24 Million

Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $729,792 - $1.51 Million	-57,600 Reduced 3.64%	1,524,760 $29.9 Million
Q3 2020 Nov 16, 2020	SELL	$11.92 - $15.87 $2.42 Million - $3.23 Million	-203,424 Reduced 11.39%	1,582,360 $20.5 Million
Q2 2020 Aug 14, 2020	SELL	$7.53 - $14.93 $3.47 Million - $6.88 Million	-460,617 Reduced 20.5%	1,785,784 $26 Million
Q1 2020 May 15, 2020	SELL	$5.69 - $17.78 $3.91 Million - $12.2 Million	-686,464 Reduced 23.41%	2,246,401 $19.1 Million
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $2.96 Million - $4.56 Million	271,845 Added 10.22%	2,932,865 $48.3 Million
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $11.3 Million - $18.8 Million	941,378 Added 54.74%	2,661,020 $37.6 Million
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $629,564 - $1.36 Million	-33,048 Reduced 1.89%	1,719,642 $34.6 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $41.74 $12.9 Million - $19 Million	-454,227 Reduced 20.58%	1,752,690 $69.7 Million
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $7.8 Million - $10.8 Million	-252,336 Reduced 10.26%	2,206,917 $76.7 Million
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $2.81 Million - $4.11 Million	-79,970 Reduced 3.15%	2,459,253 $90.4 Million
Q1 2018 May 15, 2018	SELL	$18.0 - $48.35 $1.07 Million - $2.87 Million	-59,376 Reduced 2.28%	2,539,223 $99 Million
Q4 2017 Feb 14, 2018	BUY	$13.2 - $18.1 $12.5 Million - $17.1 Million	946,086 Added 57.25%	2,598,599 $47 Million
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $21.9 Million - $28.2 Million	1,652,513	1,652,513 $27.3 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.

Account